PSI Sci
New here? Follow the money and the votes · Not sure of your district? Find your U.S. House member · Find your state legislators

H.R. 1285: To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.

Before you vote › Federal bills

H.R. 1285: To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.

113th Congress · introduced 2013-03-20 · Crime and Law Enforcement · Latest: Referred to the Subcommittee on Crime, Terrorism, Homeland Security, And Investigations.

federal

Follow this bill, step by step

  1. Where it came from: introduced 2013-03-20 · official record
  2. Who proposed it: Rep. Buchanan, Vern [R-FL-16] · what a sponsor is
  3. What happened next: no floor votes in our records yet. Why?
  4. Where it stands now: Referred to the Subcommittee on Crime, Terrorism, Homeland Security, And Investigations. Not final yet: this can still change. We check for updates every day.
  5. If it becomes law and spends money: follow the money to money laws, then agencies and contracts and grants.

What does this mean?

Official title

To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.

Plain summary

Amends the Controlled Substances Act to remove dihydrocodeinone (hydrocodone) from classification as a schedule III controlled substance. Directs the Attorney General to immediately allow manufacturers and distributors to store hydrocodone compound products in accordance with the physical security requirements for schedule III, IV, and V controlled substances for three years beginning on the date enactment of this Act. Requires the Comptroller General to submit a report on the reclassification of hydrocodone products under this Act, including: (1) an assessment of the degree to which the reclassification of such products under this Act impacts the ability of patients with legitimate medical needs, particularly those in rural areas and nursing home facilities, to access adequate pain management; and (2) recommendations necessary to address any issues relating to patient access to adequate pain management.

Congressional Research Service summary (Introduced in House), quoted unchanged (nonpartisan). Read the source.

What a vote does

A “Yea” vote

If it passes both chambers and is signed, it becomes law.

A “Nay” vote

If it is not passed, current law stays as it is.

PSI Sci description of the legislative step (not an opinion).

What does this mean? (plain words)

Official text

To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.

Source: Congressional Research Service summary (Introduced in House)

AI explanation – may be wrong, check the official text

No AI explanation yet. It takes up to a minute to write and is then saved for everyone.

Limited to a few requests an hour per person.

The strongest published arguments

Arguments for (supporters)

Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.

Arguments against (opponents)

Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.

Alternatives

Needs sources: no published alternatives yet (for example a different bill, a law instead of an amendment, or keeping current law). We only show items backed by a published source. Suggest one.

How did my representative vote? · This bill's floor votes

Officials and money

Sponsor: Rep. Buchanan, Vern [R-FL-16] · 54 cosponsors

Cost estimate: No cost estimate published yet.

Cosponsors on this site

Edward J. Markey (D-MA), Shelley Moore Capito (R-WV), Mario Diaz-Balart (R-FL), Harold Rogers (R-KY), William R. Keating (D-MA), Stephen F. Lynch (D-MA), Frederica S. Wilson (D-FL), Kathy Castor (D-FL), Scott DesJarlais (R-TN), Darrell Issa (R-CA), Todd Young (R-IN), Janice D. Schakowsky (D-IL)

Sponsor's campaign money: Rep. Buchanan, Vern [R-FL-16] reported raising $932,898 (2025–2026). Details. Shown for context only; it does not mean any donor supported this bill.

No linked floor roll calls in our collected records yet. This does not mean the bill has never had a vote. Check the official bill history.

Words on this page, explained (1)
Securities
Financial investments that can be bought and sold, such as stocks and bonds.

Plain meanings written from linked sources. All words.

Sources

Record fed-us-cong113-hr1285 · catalog fed-us-congress-bills-cong113 · updated 2026-11-15 by psicol fed-bills-cong113